(4-087) Real-world Clinical Impact of an In-house Dihydropyrimidine Dehydrogenase (DPYD) Genotyping Test on Fluoropyrimidine Dosing and Toxicity at a Multisite Cancer Center

Authors: Sarah A Morris, PharmD; D Grace Nguyen, PharmD, BCPS; Donald C Moore, PharmD, BCPS, BCOP, DPLA, FCCP; Sarah Hanson, PharmD, BCOP; Chris Larck, PharmD, BCOP, CPP; Karine Eboli Lopes, MS; Alicia Hamilton, BS; Simeon Owuor Kwange, MS; Nury Steuerwald, PhD, HCLD (ABB); James Symanowski, PhD; Laura Musselwhite, MD; Kunal C Kadakia, MD; Brinda Koya, MD; Seungjean Chai, MD; Kwabena Osei-Boateng, MD; Sini Kalapurakal, MD; Jimmy Hwang, MD; Jai N Patel, PharmD, BCOP, CPP